A previous study [5] found that early rebleeding was associated with poor neurological outcome but not with in-hospital mortality, and could suggest that rebleeding may not be responsible for sufficient brain cell damage to release S100B protein in the serum, unlike infarction. The gene discussed is S100B; the disease is infarction.